Survival from XDR-TB Is Associated with Modifiable Clinical Characteristics in Rural South Africa

• Sheela V. Shenoi ,

  * E-mail: sheela.shenoi@yale.edu

  Affiliation Department of Medicine, Section of Infectious Diseases, AIDS Program, Yale University, School of Medicine New Haven, Connecticut, United States of America

  ⨯
• Ralph P. Brooks,

  Affiliation Philanjalo Care Centre, Tugela Ferry, South Africa

  ⨯
• Russell Barbour,

  Affiliation Center for Interdisciplinary Research on AIDS, Yale University, New Haven, Connecticut, United States of America

  ⨯
• Frederick L. Altice,

  Affiliation Department of Medicine, Section of Infectious Diseases, AIDS Program, Yale University, School of Medicine New Haven, Connecticut, United States of America

  ⨯
• Daniel Zelterman,

  Affiliations Center for Interdisciplinary Research on AIDS, Yale University, New Haven, Connecticut, United States of America, Division of Biostatistics, Yale University School of Public Health, New Haven, Connecticut, United States of America

  ⨯
• Anthony P. Moll,

  Affiliation Church of Scotland Hospital, Tugela Ferry, South Africa

  ⨯
• Iqbal Master,

  Affiliation King George V Hospital, Durban, South Africa

  ⨯
• Theo L. van der Merwe,

  Affiliation Church of Scotland Hospital, Tugela Ferry, South Africa

  ⨯
• Gerald H. Friedland

  Affiliation Department of Medicine, Section of Infectious Diseases, AIDS Program, Yale University, School of Medicine New Haven, Connecticut, United States of America

  ⨯